Chargement en cours...
Biology and treatment of BRAF mutant metastatic melanoma
BRAF inhibitors were among the first systemic therapies to show clinical benefit in metastatic melanoma. Here, we review the spectrum of BRAF mutations in melanoma, their role in oncogenesis, clinicopathological associations and response to treatment. The differing biology and clinical features of V...
Enregistré dans:
| Publié dans: | Melanoma Manag |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Future Medicine Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097549/ https://ncbi.nlm.nih.gov/pubmed/30190871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt.15.38 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|